A new clinical ‘toolkit’ designed to improve the management of severe asthma has been launched by HMRI respiratory researchers.
A new clinical ‘toolkit’ designed to improve the management of severe asthma has been launched at the Thoracic Society of Australia and New Zealand’s Annual Scientific Meeting in Adelaide.
As a comprehensive and independent online resource, it gives clinicians the latest treatment information to optimise care for patients with severe asthma.
Fewer than 10% of people with asthma have severe disease yet they account for over 60% of all asthma-related healthcare costs due to hospitalisations for severe attacks and symptoms.
Project co-leader Professor Vanessa McDonald, who launched the toolkit, says there is an urgent and growing need to deliver effective care for people with severe asthma.
“This toolkit will help to meet that need by addressing a gap in existing evidence-based resources for clinicians in both primary and specialist care settings,” she says.
“Many of the contemporary asthma messages and resources are not tailored for people with severe asthma. New targeted therapies are being developed as we learn more about the underlying mechanisms of asthma, and there’s a need to translate these exciting advances into the clinic.
“In essence, the toolkit was designed by clinicians for clinicians. We invited national and international experts, as well as patients and advocate groups, to help design, develop and review the content.”
The Centre of Excellence in Severe Asthma, based at the Hunter Medical Research Institute in Newcastle, conceived and formulated the toolkit with funding by the National Health and Medical Research Council.
Professor Peter Gibson, a respiratory physician and scientist who also led the initiative, says the toolkit’s various modules put immediate information at the fingertips of clinicians while also serving as a long-term education resource.
“Severe asthma represents a different disease, placing a large burden on patients, families and society,” Professor Gibson explains. “It responds poorly to inhaled therapies and results in more frequent, and more severe, attacks that can cause hospitalisation or even death.
“We’ve included different modules in the toolkit, some of which include management, medications, comorbidities, diagnosis and assessment, paediatrics, along with a section on living with severe asthma. We believe this will be of interest both nationally and internationally.”
The Severe Asthma Toolkit is available at toolkit.severeasthma.org.au.
HMRI would like to acknowledge the Traditional Custodians of the land on which we work and live, the Awabakal and Worimi peoples, and pay our respects to Elders past and present. We recognise and respect their cultural heritage and beliefs and their continued connection to their land.
Hunter Medical Research Institute
We’re taking healthy further.
Locked Bag 1000
New Lambton
NSW, Australia, 2305
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 Hunter Medical Research Institute | ABN: 27 081 436 919
Site by Marlin Communications